Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2012.12.13
2012年第三次暂时股东大会的执法意见书
2012.11.30
关于替换保荐代表人的通告
2012.11.24
中国中投证券有限责任公司关于公司拟调解召募资金投资项目投资进度的核查意见
2012.11.24
关于变换会计师事务所的通告
2012.11.24
第二届监事会第十九次聚会决议通告
2012.11.24
关于召开2012年第三次暂时股东大会的通知通告
2012.11.24
关于调解募投项目投资进度的通告
2012.11.24
第二届董事会第二十一次聚会决议通告
2012.11.07
关于允许推行情形的通告
2012.10.16
关于变换牢靠资产折旧年限的的通告
第一页
上一页
124
125
126
127
128
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】